DAE HO LEE

DAE HO LEE

Gachon University

H-index: 37

Asia-South Korea

About DAE HO LEE

DAE HO LEE, With an exceptional h-index of 37 and a recent h-index of 26 (since 2020), a distinguished researcher at Gachon University, specializes in the field of diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis

A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease

Composite scores that include liver stiffness measurement can predict outcomes in patients with NAFLD

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta …

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation

Response to Letter to the Editor From Han and Xu:“Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”

Classification according to sequentially combined non-invasive tests carries prognostic value in patients with nafld

DAE HO LEE Information

University

Position

Department of Internal Medicine Gil Medical Center

Citations(all)

3693

Citations(since 2020)

1931

Cited By

2479

hIndex(all)

37

hIndex(since 2020)

26

i10Index(all)

78

i10Index(since 2020)

64

Email

University Profile Page

Google Scholar

DAE HO LEE Skills & Research Interests

diabetes

Top articles of DAE HO LEE

Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis

Liver international

2024/4/4

A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease

Diabetes & Metabolism Journal

2024/2/1

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

2023/9/1

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation

Experimental & molecular medicine

2023/5

Response to Letter to the Editor From Han and Xu:“Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”

The Journal of Clinical Endocrinology & Metabolism

2023/4/1

Dae Ho Lee
Dae Ho Lee

H-Index: 24

Association between DPP4 inhibitor use and the incidence of cirrhosis, ESRD, and some cancers in patients with diabetes

The Journal of Clinical Endocrinology & Metabolism

2022/11/1

Plasma metabolomics and machine learning-driven novel diagnostic signature for non-alcoholic steatohepatitis

Biomedicines

2022/7/11

Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease

Genomics

2022/7/1

A comprehensive evaluation of regression-based drug responsiveness prediction models, using cell viability inhibitory concentrations (IC50 values)

Bioinformatics

2022/5/15

Plasma aldo-keto reductase family 1 member B10 as a biomarker performs well in the diagnosis of nonalcoholic steatohepatitis and fibrosis

International Journal of Molecular Sciences

2022/5/1

Non-alcoholic fatty liver disease and the risk of diabetes mellitus by menopausal status: a nationwide cohort study

Clinical and molecular hepatology

2022/10

Neuroprotective effects of the DPP4 inhibitor vildagliptin in in vivo and in vitro models of Parkinson’s disease

International journal of molecular sciences

2022/2/21

Dae Ho Lee
Dae Ho Lee

H-Index: 24

Jungwon Seo
Jungwon Seo

H-Index: 2

Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual …

2022

Plasma metabolomics profiling and machining learning-driven prediction of nonalcoholic steatohepatitis

medRxiv

2021/10/26

Magnetic resonance-based assessments better capture pathophysiologic profiles and progression in nonalcoholic fatty liver disease

Diabetes & metabolism journal

2021/9

See List of Professors in DAE HO LEE University(Gachon University)